Neonatal Outcomes Based on Duration of Exposure to Antenatal Corticosteroids in Indicated Preterm Deliveries

Abstract

Objective To evaluate how duration of exposure to antenatal corticosteroids (ACSs) prior to delivery affects neonatal outcomes in indicated preterm deliveries.

Study Design This is a retrospective cohort of all indicated singleton preterm deliveries (23–34 weeks) in a single tertiary center from 2011 to 2014 comparing those who received ACS 2 to 7 days versus >7 days prior to delivery. The primary neonatal outcome was a composite of arterial cord pH < 7 or base excess ≤ 12, 5-minute Apgar ≤ 3, cardiopulmonary resuscitation, culture-proven neonatal sepsis, intraventricular hemorrhage grade III/IV, necrotizing enterocolitis, and neonatal death. Analyses were stratified by delivering gestational age (23^0/7–27^6/7, 28^0/7–31^6/7, and 32^0/7–33^6/7 weeks). Multivariate logistic regression refined point estimates and adjusted for confounders.

Results In total, 301 women delivered >48 hours after initial ACS dose, 230 delivered within 2 to 7 days, and 71 delivered >7 days. Infants with an interval of >7 days had no significant increase in the unadjusted composite neonatal outcome (p = 0.42), but when adjusted, the composite neonatal outcome (adjusted odds ratio [AOR]: 2.7; 95% confidence interval [CI]: 1.18–6.31) and neonatal death (AOR: 4.20; 95% CI: 1.39–12.69) were significantly increased with an ACS interval of >7 day.

Conclusion In this cohort, the benefit of ACS diminished >7 days after administration, particularly when delivery occurred at <32 weeks.

Keywords

corticosteroids - neonatal death - periviable birth - indicated preterm delivery

• References

• 1 Ballard PL. Hormonal regulation of surfactant in fetal life. Mead Johnson Symp Perinat Dev Med 1978; (14) 25-39
• 2 Bonanno C, Wapner RJ. Antenatal corticosteroid treatment: what's happened since Drs Liggins and Howie?. Am J Obstet Gynecol 2009; 200 (04) 448-457
• 3 Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; 19 (03) CD004454
• 4 Committee on Obstetric Practice. Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstet Gynecol 2017; 130 (02) e102-e109
• 5 Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50 (04) 515-525
• 6 Wapner RJ, Sorokin Y, Thom EA. , et al; National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol 2006; 195 (03) 633-642
• 7 Gates S, Brocklehurst P. Decline in effectiveness of antenatal corticosteroids with time to birth: real or artefact?. BMJ 2007; 335 (7610): 77-79
• 8 Wang MJ, Kuper SG, Steele R, Sievert RA, Tita AT, Harper LM. Outcomes of medically indicated preterm births differ by indication. Am J Perinatol 2017 Doi: 10.1055/s-0037-1615792
• 9 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (02) 377-381
• 10 Peaceman AM, Bajaj K, Kumar P, Grobman WA. The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes. Am J Obstet Gynecol 2005; 193 (3 Pt 2): 1165-1169
• 11 Ring AM, Garland JS, Stafeil BR, Carr MH, Peckman GS, Pircon RA. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study. Am J Obstet Gynecol 2007; 196 (05) 457.e1-457.e6
• 12 Melamed N, Shah J, Soraisham A. , et al. Association between antenatal corticosteroid administration-to-birth interval and outcomes of preterm neonates. Obstet Gynecol 2015; 125 (06) 1377-1384
• 13 Vermillion ST, Soper DE, Newman RB. Is betamethasone effective longer than 7 days after treatment?. Obstet Gynecol 2001; 97 (04) 491-493
• 14 Norberg H, Kowalski J, Maršál K, Norman M. Timing of antenatal corticosteroid administration and survival in extremely preterm infants: a national population-based cohort study. BJOG 2017; 124 (10) 1567-1574
• 15 Eichenwald EC, Stark AR. Management and outcomes of very low birth weight. N Engl J Med 2008; 358 (16) 1700-1711
• 16 Stout M. , et al. 589: More than just gestational age: do neonatal outcomes after spontaneous versus indicated preterm birth differ?. Am J Obstet Gynecol 2015; 212 (01) S293-S294
• 17 Travers CP, Clark RH, Spitzer AR, Das A, Garite TJ, Carlo WA. Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study. BMJ 2017; 356: j1039
• 18 Adams TM, Kinzler WL, Chavez MR, Fazzari MJ, Vintzileos AM. Practice patterns in the timing of antenatal corticosteroids for fetal lung maturity. J Matern Fetal Neonatal Med 2015; 28 (13) 1598-1601
• 19 Adams TM, Kinzler WL, Chavez MR, Vintzileos AM. The timing of administration of antenatal corticosteroids in women with indicated preterm birth. Am J Obstet Gynecol 2015; 212 (05) 645.e1-645.e4